The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income | 1,154,300 | 1,182,900 | 908,000 | 1,025,100 |
| Stock-based compensation | 21,800 | 28,900 | 24,000 | 20,700 |
| Amortization of purchased intangibles | 56,100 | 55,900 | 56,200 | 56,100 |
| Depreciation and amortization | 27,200 | 26,500 | 26,400 | 27,300 |
| Net realized and unrealized (gains) losses on investments | -22,900 | 349,800 | 400 | 0 |
| Deferred income taxes | -13,400 | 21,300 | -6,700 | -13,300 |
| Accounts receivable | 295,800 | -2,800 | -25,500 | -101,400 |
| Other current assets | 50,100 | -3,800 | -2,700 | 24,600 |
| Other assets | -3,500 | 31,500 | -51,600 | -13,300 |
| Accounts payable | 3,600 | -3,100 | -17,500 | -7,800 |
| Income taxes payable | 327,600 | 63,500 | -700 | -252,600 |
| Other current liabilities | 20,900 | 95,900 | -77,200 | 125,000 |
| Other liabilities | -7,600 | -27,000 | 1,600 | -6,400 |
| Other | 11,100 | -63,800 | 25,400 | 5,700 |
| Cash provided by (used in) operating activity, including discontinued operation | 1,259,900 | 1,133,900 | 968,100 | 1,058,500 |
| Proceeds from maturities of available-for-sale marketable securities | 1,100 | 1,700 | 1,400 | 1,200 |
| Purchases of available-for-sale marketable securities | 800 | 1,100 | 1,100 | 800 |
| Purchases of property, net | 21,800 | 32,500 | 18,400 | 18,400 |
| Investments in privately-held equity investments | 1,500 | 7,600 | 1,000 | 0 |
| Proceeds from sale of business ventures | - | 1,591,400 | 0 | 0 |
| Net cash used in investing activities | -23,000 | 1,551,900 | -19,100 | -18,000 |
| Proceeds from debt, net of issuance costs | 0 | 0 | -1,700 | 0 |
| Repayment of other borrowings, including call premiums | - | 750,000 | - | - |
| Repayment of debt | 0 | - | 0 | 0 |
| Cash dividends | 2,697,600 | 455,000 | 455,300 | 455,300 |
| Repurchase of class a common stock, including costs | 538,700 | 257,900 | 0 | 8,200 |
| Change in performance bond and guaranty fund contributions | -5,379,200 | 110,906,300 | -6,883,200 | -21,463,400 |
| Employee taxes paid on restricted stock vesting | 22,000 | 2,900 | 22,200 | 600 |
| Other | -4,400 | 100 | -4,300 | -100 |
| Net cash provided by financing activities | 2,116,500 | 9,899,200 | 6,399,700 | 20,999,200 |
| Net change in cash, cash equivalents and restricted cash | 3,353,400 | 12,585,000 | 7,348,700 | 22,039,700 |
| Cash, cash equivalents, restricted cash and restricted cash equivalents, beginning balance | 164,079,500 | 122,106,100 | 122,106,100 | 122,106,100 |
| Cash, cash equivalents, restricted cash and restricted cash equivalents, ending balance | 167,432,900 | 12,585,000 | 7,348,700 | 144,145,800 |
CME GROUP INC. (CME)
CME GROUP INC. (CME)